This protocol is judged by an institutional assessment board, an independent team that evaluations any clinical trials involving individuals. If a study consists of a Program I drug, as soon as the board approves the protocol as ethical, the researchers have to make an application for an investigational new drug (IND) quantity with the FDA.He said